Press release Biocartis Group NV: Biocartis Reports Results of Third Quarter of 2022
globenewswire.com
news
2022-10-21 00:00:00

English Dutch THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW. PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 21 October 2022, 07:00 CEST Biocartis Reports Results of Third Quarter of 2022:Full-year guidance raised for product gross margin, despite expected lower product revenues Improving operating cash burn guidance Mechelen, Belgium, 21 October 2022 – Biocartis Group NV (the "Company" or "Biocartis"), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update for the third quarter of 2022 and the outlook for the full year 2022.
